Literature DB >> 28001088

Glioblastoma in the elderly: treatment patterns and survival.

Jean-Aine Pretanvil1, Isaac Q Salinas1, David E Piccioni1.   

Abstract

AIM: The optimal treatment for elderly glioblastoma patients is unclear. We conducted a retrospective review of the California Cancer Registry to examine treatment patterns and survival by age.
METHODS: We identified 2670 adult patients from the California Cancer Registry with glioblastoma. We compared the extent of resection, treatment type and modality.
RESULTS: Elderly patients had the greatest overall survival (OS) with combined surgery, radiation and chemotherapy. However, they were more likely to undergo biopsy and less likely to receive combined radiation and chemotherapy than patients <70.
CONCLUSION: OS was maximized in elderly patients who were able to get some surgical resection and undergo combined radiation and chemotherapy. OS survival in some elderly patients may be improved by more extensive therapy.

Entities:  

Keywords:  California cancer registry; chemotherapy; elderly; glioblastoma; overall survival; radiation; retrospective study; surgery; treatment

Mesh:

Year:  2016        PMID: 28001088      PMCID: PMC6027939          DOI: 10.2217/cns-2016-0023

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  22 in total

1.  Patterns of care in elderly glioblastoma patients.

Authors:  Fabio M Iwamoto; Anne S Reiner; Katherine S Panageas; Elena B Elkin; Lauren E Abrey
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

2.  Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Authors:  Annika Malmström; Bjørn Henning Grønberg; Christine Marosi; Roger Stupp; Didier Frappaz; Henrik Schultz; Ufuk Abacioglu; Björn Tavelin; Benoit Lhermitte; Monika E Hegi; Johan Rosell; Roger Henriksson
Journal:  Lancet Oncol       Date:  2012-08-08       Impact factor: 41.316

3.  Glioblastoma therapy in the elderly: one age does not fit all.

Authors:  Phioanh Leia Nghiemphu; Timothy Cloughesy
Journal:  Lancet Oncol       Date:  2012-08-08       Impact factor: 41.316

4.  Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.

Authors:  Jaime Gállego Pérez-Larraya; François Ducray; Olivier Chinot; Isabelle Catry-Thomas; Luc Taillandier; Jean-Sébastien Guillamo; Chantal Campello; Annick Monjour; Stéphanie Cartalat-Carel; Maryline Barrie; Aymeri Huchet; Patrick Beauchesne; Mona Matta; Karima Mokhtari; Marie-Laure Tanguy; Jérôme Honnorat; Jean-Yves Delattre
Journal:  J Clin Oncol       Date:  2011-06-27       Impact factor: 44.544

5.  Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Authors:  Daniela Kuhnt; Andreas Becker; Oliver Ganslandt; Miriam Bauer; Michael Buchfelder; Christopher Nimsky
Journal:  Neuro Oncol       Date:  2011-09-12       Impact factor: 12.300

Review 6.  Survival in glioblastoma: a review on the impact of treatment modalities.

Authors:  P D Delgado-López; E M Corrales-García
Journal:  Clin Transl Oncol       Date:  2016-03-10       Impact factor: 3.405

7.  Glioblastoma multiforme in the very elderly.

Authors:  Felicity V Connon; Mark A Rosenthal; Katherine Drummond
Journal:  Neurosurg Rev       Date:  2015-07-26       Impact factor: 3.042

8.  Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

Authors:  Alba A Brandes; Enrico Franceschi; Alicia Tosoni; Francesca Benevento; Luciano Scopece; Valeria Mazzocchi; Antonella Bacci; Raffaele Agati; Fabio Calbucci; Mario Ermani
Journal:  Cancer       Date:  2009-08-01       Impact factor: 6.860

9.  Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.

Authors:  Stephanie E Combs; Johanna Wagner; Marc Bischof; Thomas Welzel; Florian Wagner; Jürgen Debus; Daniela Schulz-Ertner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

10.  Radiotherapy for glioblastoma in the elderly.

Authors:  Florence Keime-Guibert; Olivier Chinot; Luc Taillandier; Stéphanie Cartalat-Carel; Marc Frenay; Guy Kantor; Jean-Sébastien Guillamo; Eric Jadaud; Philippe Colin; Pierre-Yves Bondiau; Philippe Meneï; Hugues Loiseau; Valérie Bernier; Jérôme Honnorat; Maryline Barrié; Karima Mokhtari; Jean-Jacques Mazeron; Anne Bissery; Jean-Yves Delattre
Journal:  N Engl J Med       Date:  2007-04-12       Impact factor: 91.245

View more
  9 in total

1.  Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway.

Authors:  Line Sagerup Bjorland; Oystein Fluge; Bjornar Gilje; Rupavathana Mahesparan; Elisabeth Farbu
Journal:  BMJ Open       Date:  2021-03-12       Impact factor: 2.692

Review 2.  Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas.

Authors:  Shalini Sundramurthi Chelliah; Ervin Ashley Lourdes Paul; Muhamad Noor Alfarizal Kamarudin; Ishwar Parhar
Journal:  Molecules       Date:  2021-02-22       Impact factor: 4.411

3.  Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.

Authors:  Melanie Barz; Julia Gerhardt; Stefanie Bette; A Kaywan Aftahy; Thomas Huber; Stephanie E Combs; Yu-Mi Ryang; Benedikt Wiestler; Marco Skardelly; Irina Gepfner-Tuma; Felix Behling; Friederike Schmidt-Graf; Bernhard Meyer; Jens Gempt
Journal:  BMC Neurol       Date:  2021-11-15       Impact factor: 2.474

Review 4.  Newly Diagnosed Glioblastoma in Elderly Patients.

Authors:  Carlen A Yuen; Marissa Barbaro; Aya Haggiagi
Journal:  Curr Oncol Rep       Date:  2022-02-05       Impact factor: 5.945

Review 5.  Guiding Treatment Choices for Elderly Patients with Glioblastoma by a Comprehensive Geriatric Assessment.

Authors:  Carola Lütgendorf-Caucig; Christian Freyschlag; Eva Katharina Masel; Christine Marosi
Journal:  Curr Oncol Rep       Date:  2020-07-10       Impact factor: 5.075

6.  Connexin 43 C-terminus directly inhibits the hyperphosphorylation of Akt/ERK through protein-protein interactions in glioblastoma.

Authors:  Jing-Ya Kuang; Yu-Feng Guo; Ying Chen; Jun Wang; Jiang-Jie Duan; Xiao-Li He; Lin Li; Shi-Cang Yu; Xiu-Wu Bian
Journal:  Cancer Sci       Date:  2018-08-09       Impact factor: 6.716

7.  "Do I want to know it all?" A qualitative study of glioma patients' perspectives on receiving information about their diagnosis and prognosis.

Authors:  Annika Malmström; Lisa Åkesson; Peter Milos; Munila Mudaisi; Helena Bruhn; Michael Strandeus; Marit Karlsson
Journal:  Support Care Cancer       Date:  2020-10-30       Impact factor: 3.603

Review 8.  Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management.

Authors:  Manik Chahal; Brian Thiessen; Caroline Mariano
Journal:  Curr Oncol       Date:  2022-01-14       Impact factor: 3.677

9.  Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide.

Authors:  Hendrik-Jan Mijderwijk; Marcel A Kamp; Kerstin Berger; Bernd Turowski; Jörg Felsberg; Bastian Malzkorn; Guido Reifenberger; Hans-Jakob Steiger; Wilfried Budach; Jan Haussmann; Johannes Knipps; Marion Rapp; Daniel Hänggi; Michael Sabel
Journal:  J Cancer Res Clin Oncol       Date:  2020-08-03       Impact factor: 4.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.